Evoke Wealth, LLC Summit Therapeutics Inc. Transaction History
Evoke Wealth, LLC
- $4.37 Trillion
- Q2 2025
A detailed history of Evoke Wealth, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Evoke Wealth, LLC holds 10,000 shares of SMMT stock, worth $213,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 13,414
25.45%
Holding current value
$213,500
Previous $259 Million
17.76%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding SMMT
# of Institutions
263Shares Held
90.3MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$720 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$185 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$169 Million0.0% of portfolio
-
State Street Corp Boston, MA4.02MShares$85.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$83.4 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.3B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...